Trevi Therapeutics, Inc. TRVI Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum.
The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s share based compensation arrangement by share based payment award fair value assumptions risk free interest rate minimum.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s share based compensation arrangement by share based payment award fair value assumptions risk free interest rate minimum?
- Trevi Therapeutics, Inc. (TRVI) reported share based compensation arrangement by share based payment award fair value assumptions risk free interest rate minimum of 3.8% in Q4 2025.
- What does share based compensation arrangement by share based payment award fair value assumptions risk free interest rate minimum mean?
- The lower bound of the risk-free interest rate assumption used in the valuation models for employee stock options. This input is critical for determining the fair value of equity awards and reflects the prevailing market environment at the time of grant.